Display options
Share it on

J Clin Diagn Res. 2016 Jun;10(6):BE01-6. doi: 10.7860/JCDR/2016/18712.7922. Epub 2016 Jun 01.

Aptamers in Therapeutics.

Journal of clinical and diagnostic research : JCDR

Abhishek Parashar

Affiliations

  1. Research Scholar, Animal Biochemistry Division, National Dairy Research Institute , Karnal, India .

PMID: 27504277 PMCID: PMC4963637 DOI: 10.7860/JCDR/2016/18712.7922

Abstract

Aptamers are single strand DNA or RNA molecules, selected by an iterative process known as Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Due to various advantages of aptamers such as high temperature stability, animal free, cost effective production and its high affinity and selectivity for its target make them attractive alternatives to monoclonal antibody for use in diagnostic and therapeutic purposes. Aptamer has been generated against vesicular endothelial growth factor 165 involved in age related macular degeneracy. Macugen was the first FDA approved aptamer based drug that was commercialized. Later other aptamers were also developed against blood clotting proteins, cancer proteins, antibody E, agents involved in diabetes nephropathy, autoantibodies involved in autoimmune disorders, etc. Aptamers have also been developed against viruses and could work with other antiviral agents in treating infections.

Keywords: Aptamer; Cancer; Diabetes nephropathy; Macugen; SELEX

References

  1. Biochem Biophys Res Commun. 2012 Jan 6;417(1):521-7 - PubMed
  2. J Agric Food Chem. 2015 Mar 4;63(8):2189-97 - PubMed
  3. Immunopharmacology. 1999 May;42(1-3):219-30 - PubMed
  4. J Thromb Haemost. 2013 Jul;11(7):1364-73 - PubMed
  5. Int J Cancer. 2002 Mar 20;98(3):362-9 - PubMed
  6. Lab Invest. 2007 May;87(5):409-16 - PubMed
  7. J Virol. 2015 Sep;89(18):9281-7 - PubMed
  8. Cancer Res. 2006 Nov 1;66(21):10560-6 - PubMed
  9. Nat Genet. 2006 Sep;38(9):1049-54 - PubMed
  10. Eur J Pharm Sci. 2013 Jan 23;48(1-2):259-71 - PubMed
  11. Cancer Res. 2002 Jul 15;62(14):4029-33 - PubMed
  12. J Mol Recognit. 2014 Aug;27(8):493-500 - PubMed
  13. Mol Vis. 2006 Mar 06;12:156-8 - PubMed
  14. Br J Ophthalmol. 2006 Sep;90(9):1142-5 - PubMed
  15. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13174-9 - PubMed
  16. Nature. 1992 Feb 6;355(6360):564-6 - PubMed
  17. Mol Vis. 2005 Dec 19;11:1135-40 - PubMed
  18. Annu Rev Immunol. 2003;21:579-628 - PubMed
  19. Nat Rev Drug Discov. 2006 Feb;5(2):123-32 - PubMed
  20. Cancer Res. 2002 Oct 1;62(19):5476-84 - PubMed
  21. J Biol Chem. 2001 May 11;276(19):16464-8 - PubMed
  22. Biochemistry. 1996 Nov 12;35(45):14413-24 - PubMed
  23. J Agric Food Chem. 2015 Mar 18;63(10):2647-53 - PubMed
  24. Science. 1990 Aug 3;249(4968):505-10 - PubMed
  25. Biochem Biophys Res Commun. 2002 Jan 18;290(2):656-62 - PubMed
  26. Ann Surg. 2012 Feb;255(2):319-25 - PubMed
  27. PLoS One. 2015 May 04;10(5):e0125863 - PubMed
  28. Nat Commun. 2015 Apr 22;6:6923 - PubMed
  29. J Biol Chem. 2010 Dec 17;285(51):40012-8 - PubMed
  30. Oligonucleotides. 2009 Sep;19(3):273-80 - PubMed
  31. Clin Cancer Res. 1996 Sep;2(9):1445-51 - PubMed
  32. Nucleic Acids Res. 2004 Oct 27;32(19):5757-65 - PubMed
  33. Nucleic Acid Ther. 2012 Dec;22(6):391-8 - PubMed
  34. Mol Immunol. 2004 Jun;41(4):355-67 - PubMed
  35. Nat Rev Drug Discov. 2010 Jul;9(7):537-50 - PubMed
  36. J Cell Biol. 2003 Nov 24;163(4):871-8 - PubMed
  37. Circulation. 2007 Dec 4;116(23):2678-86 - PubMed
  38. PLoS One. 2015 Mar 31;10(3):e0123034 - PubMed
  39. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15416-21 - PubMed
  40. Mol Ther Nucleic Acids. 2014 Jun 17;3:e169 - PubMed
  41. Sci Rep. 2015 May 22;5:10326 - PubMed
  42. Anal Chem. 2012 Feb 7;84(3):1669-76 - PubMed
  43. Appl Microbiol Biotechnol. 2005 Dec;69(4):367-74 - PubMed
  44. Clin Ther. 2006 Jan;28(1):36-44 - PubMed
  45. Am J Pathol. 2008 Mar;172(3):628-37 - PubMed
  46. Nature. 2002 Sep 5;419(6902):90-4 - PubMed
  47. J Am Chem Soc. 2004 Jan 14;126(1):20-1 - PubMed
  48. Prostate. 2000 Dec 1;45(4):350-4 - PubMed
  49. J Biol Chem. 1993 Oct 5;268(28):20808-11 - PubMed
  50. J Mol Biol. 1997 Oct 10;272(5):688-98 - PubMed
  51. Nucleic Acids Symp Ser (Oxf). 2008;(52):61-2 - PubMed
  52. RNA. 2006 Nov;12(11):1970-9 - PubMed
  53. Mol Vis. 2006 Jul 20;12:796-801 - PubMed
  54. Biochem Biophys Res Commun. 2001 Feb 16;281(1):237-43 - PubMed
  55. Nucleic Acids Symp Ser (Oxf). 2008;(52):493-4 - PubMed
  56. Curr Opin Mol Ther. 2003 Dec;5(6):673-9 - PubMed
  57. Theranostics. 2015 Jun 06;5(9):985-94 - PubMed
  58. Biochem Biophys Res Commun. 2003 Jan 10;300(2):516-23 - PubMed
  59. PLoS One. 2012;7(5):e37789 - PubMed
  60. J Exp Med. 2003 Aug 4;198(3):483-9 - PubMed
  61. Anal Chem. 2010 Oct 15;82(20):8642-9 - PubMed
  62. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):749-53 - PubMed
  63. Nucleic Acids Res. 2011 Oct;39(18):e122 - PubMed
  64. Exp Mol Pathol. 2009 Jun;86(3):151-64 - PubMed
  65. Mol Cancer Ther. 2009 Sep;8(9):2664-73 - PubMed
  66. Sensors (Basel). 2012;12(1):612-31 - PubMed
  67. Int J Nanomedicine. 2006;1(3):263-8 - PubMed
  68. PLoS One. 2011;6(9):e24071 - PubMed
  69. J Biol Chem. 2001 Dec 28;276(52):48644-54 - PubMed
  70. Diabetes. 2013 Sep;62(9):3241-50 - PubMed
  71. J Agric Food Chem. 2014 Feb 5;62(5):1032-7 - PubMed
  72. Cancer Lett. 2011 Dec 26;313(1):76-83 - PubMed
  73. Antimicrob Agents Chemother. 2013 Oct;57(10):4937-44 - PubMed
  74. J Clin Invest. 2014 Jul;124(7):2977-87 - PubMed
  75. Int J Cancer. 2002 Jul 10;100(2):228-37 - PubMed
  76. J Exp Med. 1996 Aug 1;184(2):315-24 - PubMed
  77. Cancer Res. 2001 Apr 1;61(7):2929-34 - PubMed
  78. Nature. 1990 Aug 30;346(6287):818-22 - PubMed

Publication Types